Activity of lurbinectedin as single agent and in combination in patients with advanced small cell lung cancer (SCLC)

Authors :: Pilar Lardelli
V. Moreno
Arturo Soto-Matos
Emiliano Calvo
M.P. Lopez Criado
J.A. Lopez-Vilarino de Ramos
Martin Forster
X.E. Luepke-Estefan
M.E. Olmedo García
Carmen Kahatt
Source :: Lung Cancer. 115:S72
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Oncology
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Cancer Research
business.industry
Lurbinectedin
Hematology
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Cancer research
Medicine
In patient
Single agent
Non small cell
business

Full Text Access

Tools